-
D287247-50mgProduct Describtion:DuP-697 is a member of the vicinal diaryl heterocycles and a potent, irreversible, selective and orally active COX-2 inhibitor (IC50 of 10 nM and 800 nM for human COX-2 and COX-1, respectively). DuP-697 exerts antiproliferative
-
D287247-5mgProduct Describtion:DuP-697 is a member of the vicinal diaryl heterocycles and a potent, irreversible, selective and orally active COX-2 inhibitor (IC50 of 10 nM and 800 nM for human COX-2 and COX-1, respectively). DuP-697 exerts antiproliferative
-
Ab169296-100μgDupilumab is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis.Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level<: 1.0EU/mg.
-
Ab169296-10mgDupilumab is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis.Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level<: 1.0EU/mg.
-
Ab169296-1mgDupilumab is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis.Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level<: 1.0EU/mg.
-
Ab169296-5mgDupilumab is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis.Purity>:95% (SDS-PAGE&:SEC)Endotoxin Level<: 1.0EU/mg.
-
D409297-100mgDynamin inhibitory peptide TFA.
-
D409297-10mgDynamin inhibitory peptide TFA.
-
D409297-1mgDynamin inhibitory peptide TFA.
-
D409297-25mgDynamin inhibitory peptide TFA.
-
D409297-50mgDynamin inhibitory peptide TFA.
-
D409297-5mgDynamin inhibitory peptide TFA.